Abstract 131: Recurrent Acute Cardiovascular Events and Statin Use [Session Title: Poster Session AM]
Conclusion: While statin use substantially increased after an index CV event, nearly 40% of patients remained untreated, increasing their recurrent CV event risk by 76%. Initiation and continuation of statin therapy after CV events remains a large public health opportunity for patients with ASCVD.
Source: Circulation: Cardiovascular Quality and Outcomes - Category: Cardiology Authors: Tecson, K. M., Kluger, A. Y., DiMario, S., Harrison, D. J., McCullough, P. A. Tags: Session Title: Poster Session AM Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Heart Attack | Hypertension | Insurance | International Medicine & Public Health | Ischemic Stroke | Statin Therapy | Stroke | Study